Literature DB >> 26395884

Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations.

Catherine A Brownstein1,2, Alan H Beggs3,4, Lance Rodan3, Jiahai Shi5,6, Meghan C Towne3,4, Renee Pelletier3,4, Siqi Cao3,7,4, Paul A Rosenberg8, David K Urion8, Jonathan Picker3, Wen-Hann Tan3, Pankaj B Agrawal9,10,11.   

Abstract

Mutations in the KCNA1 gene are known to cause episodic ataxia/myokymia syndrome type 1 (EA1). Here, we describe two families with unique presentations who were enrolled in an IRB-approved study, extensively phenotyped, and whole exome sequencing (WES) performed. Family 1 had a diagnosis of isolated cataplexy triggered by sudden physical exertion in multiple affected individuals with heterogeneous neurological findings. All enrolled affected members carried a KCNA1 c.941T>C (p.I314T) mutation. Family 2 had an 8-year-old patient with muscle spasms with rigidity for whom WES revealed a previously reported heterozygous missense mutation in KCNA1 c.677C>G (p.T226R), confirming the diagnosis of EA1 without ataxia. WES identified variants in KCNA1 that explain both phenotypes expanding the phenotypic spectrum of diseases associated with mutations of this gene. KCNA1 mutations should be considered in patients of all ages with episodic neurological phenotypes, even when ataxia is not present. This is an example of the power of genomic approaches to identify pathogenic mutations in unsuspected genes responsible for heterogeneous diseases.

Entities:  

Keywords:  Cataplexy; Episodic ataxia; Hypertonia; KCNA1; Whole exome sequencing

Mesh:

Substances:

Year:  2015        PMID: 26395884      PMCID: PMC4911217          DOI: 10.1007/s10048-015-0460-2

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  16 in total

1.  A novel KCNA1 mutation causing episodic ataxia type I.

Authors:  Saskia Lassche; Sergio Lainez; Bastiaan R Bloem; Bart P C van de Warrenburg; Jeannette Hofmeijer; Henny H Lemmink; Joost G J Hoenderop; René J M Bindels; Gea Drost
Journal:  Muscle Nerve       Date:  2014-07-14       Impact factor: 3.217

2.  Characterization of the Kv1.1 I262T and S342I mutations associated with episodic ataxia 1 with distinct phenotypes.

Authors:  Jing Zhu; Rami Alsaber; Jian Zhao; Eugenia Ribeiro-Hurley; William B Thornhill
Journal:  Arch Biochem Biophys       Date:  2012-05-17       Impact factor: 4.013

3.  Episodic ataxia type 1 without episodic ataxia: the diagnostic utility of nerve excitability studies in individuals with KCNA1 mutations.

Authors:  S Veronica Tan; Elizabeth Wraige; Karine Lascelles; Hugh Bostock
Journal:  Dev Med Child Neurol       Date:  2013-08-05       Impact factor: 5.449

4.  Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release.

Authors:  Joost H Heeroma; Christian Henneberger; Sanjeev Rajakulendran; Michael G Hanna; Stephanie Schorge; Dimitri M Kullmann
Journal:  Dis Model Mech       Date:  2009-09-24       Impact factor: 5.758

5.  Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia.

Authors:  Jenny van der Wijst; Bob Glaudemans; Hanka Venselaar; Anil V Nair; Anna-Lena Forst; Joost G J Hoenderop; René J M Bindels
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

Review 6.  Acetazolamide-responsive ataxia.

Authors:  Vikas Kotagal
Journal:  Semin Neurol       Date:  2013-05-15       Impact factor: 3.420

7.  Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment.

Authors:  Stephen B Long; Xiao Tao; Ernest B Campbell; Roderick MacKinnon
Journal:  Nature       Date:  2007-11-15       Impact factor: 49.962

8.  Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays.

Authors:  Radoje Drmanac; Andrew B Sparks; Matthew J Callow; Aaron L Halpern; Norman L Burns; Bahram G Kermani; Paolo Carnevali; Igor Nazarenko; Geoffrey B Nilsen; George Yeung; Fredrik Dahl; Andres Fernandez; Bryan Staker; Krishna P Pant; Jonathan Baccash; Adam P Borcherding; Anushka Brownley; Ryan Cedeno; Linsu Chen; Dan Chernikoff; Alex Cheung; Razvan Chirita; Benjamin Curson; Jessica C Ebert; Coleen R Hacker; Robert Hartlage; Brian Hauser; Steve Huang; Yuan Jiang; Vitali Karpinchyk; Mark Koenig; Calvin Kong; Tom Landers; Catherine Le; Jia Liu; Celeste E McBride; Matt Morenzoni; Robert E Morey; Karl Mutch; Helena Perazich; Kimberly Perry; Brock A Peters; Joe Peterson; Charit L Pethiyagoda; Kaliprasad Pothuraju; Claudia Richter; Abraham M Rosenbaum; Shaunak Roy; Jay Shafto; Uladzislau Sharanhovich; Karen W Shannon; Conrad G Sheppy; Michel Sun; Joseph V Thakuria; Anne Tran; Dylan Vu; Alexander Wait Zaranek; Xiaodi Wu; Snezana Drmanac; Arnold R Oliphant; William C Banyai; Bruce Martin; Dennis G Ballinger; George M Church; Clifford A Reid
Journal:  Science       Date:  2009-11-05       Impact factor: 47.728

9.  Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.

Authors:  D L Browne; S T Gancher; J G Nutt; E R Brunt; E A Smith; P Kramer; M Litt
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

10.  Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.

Authors:  Tracey D Graves; Yoon-Hee Cha; Angelika F Hahn; Richard Barohn; Mohammed K Salajegheh; Robert C Griggs; Brian N Bundy; Joanna C Jen; Robert W Baloh; Michael G Hanna
Journal:  Brain       Date:  2014-02-26       Impact factor: 13.501

View more
  14 in total

1.  Episodic Ataxia Type 1 (K-channelopathy) Manifesting as Paroxysmal Nonkinesogenic Dyskinesia: Expanding the Phenotype.

Authors:  Kallol K Set; Debabrata Ghosh; A H M Huq; Aimee F Luat
Journal:  Mov Disord Clin Pract       Date:  2017-07-31

2.  A de novo KCNA1 Mutation in a Patient with Tetany and Hypomagnesemia.

Authors:  Jenny van der Wijst; Martin Konrad; Sjoerd A J Verkaart; Marcin Tkaczyk; Femke Latta; Janine Altmüller; Holger Thiele; Bodo Beck; Karl Peter Schlingmann; Jeroen H F de Baaij
Journal:  Nephron       Date:  2018-05-23       Impact factor: 2.847

Review 3.  Cataplexy and Its Mimics: Clinical Recognition and Management.

Authors:  Sigrid Pillen; Fabio Pizza; Karlien Dhondt; Thomas E Scammell; Sebastiaan Overeem
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

4.  De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability.

Authors:  Sébastien Küry; Geeske M van Woerden; Thomas Besnard; Martina Proietti Onori; Xénia Latypova; Meghan C Towne; Megan T Cho; Trine E Prescott; Melissa A Ploeg; Stephan Sanders; Holly A F Stessman; Aurora Pujol; Ben Distel; Laurie A Robak; Jonathan A Bernstein; Anne-Sophie Denommé-Pichon; Gaëtan Lesca; Elizabeth A Sellars; Jonathan Berg; Wilfrid Carré; Øyvind Løvold Busk; Bregje W M van Bon; Jeff L Waugh; Matthew Deardorff; George E Hoganson; Katherine B Bosanko; Diana S Johnson; Tabib Dabir; Øystein Lunde Holla; Ajoy Sarkar; Kristian Tveten; Julitta de Bellescize; Geir J Braathen; Paulien A Terhal; Dorothy K Grange; Arie van Haeringen; Christina Lam; Ghayda Mirzaa; Jennifer Burton; Elizabeth J Bhoj; Jessica Douglas; Avni B Santani; Addie I Nesbitt; Katherine L Helbig; Marisa V Andrews; Amber Begtrup; Sha Tang; Koen L I van Gassen; Jane Juusola; Kimberly Foss; Gregory M Enns; Ute Moog; Katrin Hinderhofer; Nagarajan Paramasivam; Sharyn Lincoln; Brandon H Kusako; Pierre Lindenbaum; Eric Charpentier; Catherine B Nowak; Elouan Cherot; Thomas Simonet; Claudia A L Ruivenkamp; Sihoun Hahn; Catherine A Brownstein; Fan Xia; Sébastien Schmitt; Wallid Deb; Dominique Bonneau; Mathilde Nizon; Delphine Quinquis; Jamel Chelly; Gabrielle Rudolf; Damien Sanlaville; Philippe Parent; Brigitte Gilbert-Dussardier; Annick Toutain; Vernon R Sutton; Jenny Thies; Lisenka E L M Peart-Vissers; Pierre Boisseau; Marie Vincent; Andreas M Grabrucker; Christèle Dubourg; Wen-Hann Tan; Nienke E Verbeek; Martin Granzow; Gijs W E Santen; Jay Shendure; Bertrand Isidor; Laurent Pasquier; Richard Redon; Yaping Yang; Matthew W State; Tjitske Kleefstra; Benjamin Cogné; Slavé Petrovski; Kyle Retterer; Evan E Eichler; Jill A Rosenfeld; Pankaj B Agrawal; Stéphane Bézieau; Sylvie Odent; Ype Elgersma; Sandra Mercier
Journal:  Am J Hum Genet       Date:  2017-11-02       Impact factor: 11.025

5.  A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia.

Authors:  Tiago A Mestre; Andreea Manole; Heather MacDonald; Sheila Riazi; Natalia Kraeva; Michael G Hanna; Anthony E Lang; Roope Männikkö; Grace Yoon
Journal:  Neurogenetics       Date:  2016-06-08       Impact factor: 2.660

Review 6.  Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

Authors:  Kelsey Paulhus; Lauren Ammerman; Edward Glasscock
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

7.  Neuromuscular tetanic hyperexcitability syndrome associated to a heterozygous Kv1.1 N255D mutation with normal serum magnesium levels.

Authors:  Francesca Bianchi; Costanza Simoncini; Raffaella Brugnoni; Giulia Ricci; Gabriele Siciliano
Journal:  Acta Myol       Date:  2020-03-01

Review 8.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 9.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

Review 10.  Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.

Authors:  Maria Cristina D'Adamo; Antonella Liantonio; Jean-Francois Rolland; Mauro Pessia; Paola Imbrici
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.